In another report, the same dual β1-integrin/EGFR inhibition approach, as well as KRAS or BRAF depletion and 5-FU-treatment failed to modulate the radiosensitivity of colorectal carcinoma cells (116). Here, KRAS is linked to colorectal carcinoma.